Hydroxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Details for Australian Patent Application No. 2009204025 (hide)

Owner Array BioPharma Inc. Genentech, Inc.

Inventors Blake, James F.; Zhang, Birong; Do, Steven; Xu, Rui; Spencer, Keith Lee; Liang, Jun; Bencsik, Josef R.; Safina, Brian; Kallan, Nicholas C.; Chabot, Christine; Xiao, Dengming; Mitchell, Ian S.

Agent Pizzeys

Pub. Number AU-A-2009204025

PCT Pub. Number WO2009/089459

Priority 61/020,092 09.01.08 US

Filing date 9 January 2009

Wipo publication date 16 July 2009

International Classifications

C07D 239/70 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/089459 Priority application(s): WO2009/089459

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009204048-(1-azinone) -substituted pyridoindoles as MCH antagonists

2009204019-Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor